T-box binding protein type two (TBX2) is an immediate early gene target in retinoic-acid-treated B16 murine melanoma cells.

Boskovic, Goran

T-box binding protein type two (TBX2) is an immediate early gene target in retinoic-acid-treated B16 murine melanoma cells. [electronic resource] - Experimental cell research May 2004 - 281-9 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0014-4827

10.1016/j.yexcr.2003.12.017 doi


Animals
Cell Differentiation--drug effects
Cell Division--drug effects
Cell Extracts
Cell Line, Tumor
Cell Nucleus--metabolism
Gene Expression Regulation, Neoplastic--drug effects
Genes, Immediate-Early
Genes, Reporter
HeLa Cells
Humans
Luciferases--genetics
Melanocytes--cytology
Melanoma, Experimental--genetics
Mice
Point Mutation
Promoter Regions, Genetic--drug effects
RNA, Messenger--metabolism
Receptors, Retinoic Acid--metabolism
Response Elements--genetics
T-Box Domain Proteins--drug effects
Tretinoin--pharmacology